<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Data</journal-id>
    <journal-title-group>
      <journal-title>Scientific Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2052-4463</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9039076</article-id>
    <article-id pub-id-type="publisher-id">1287</article-id>
    <article-id pub-id-type="doi">10.1038/s41597-022-01287-5</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Descriptor</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HORDB a comprehensive database of peptide hormones</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zhu</surname>
          <given-names>Ning</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dong</surname>
          <given-names>Fanyi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shi</surname>
          <given-names>Guobang</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Lao</surname>
          <given-names>Xingzhen</given-names>
        </name>
        <address>
          <email>lao@cpu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1810-5842</contrib-id>
        <name>
          <surname>Zheng</surname>
          <given-names>Heng</given-names>
        </name>
        <address>
          <email>zhengh18@hotmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.254147.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 9776 7793</institution-id><institution>School of Life Science and Technology, </institution><institution>China Pharmaceutical University, </institution></institution-wrap>24 Tongjiaxiang, Nanjing, 210009 P. R. China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>4</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>25</day>
      <month>4</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>9</volume>
    <elocation-id>187</elocation-id>
    <history>
      <date date-type="received">
        <day>3</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>14</day>
        <month>3</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Peptide hormones (also known as hormone peptides and polypeptide hormones) are hormones composed of peptides and are signal transduction molecules produced by a class of multicellular organisms. It plays an important role in the physiological and behavioral regulation of animals and humans as well as in the growth of plants. In order to promote the research on peptide hormones, we constructed HORDB database. The database currently has a total of 6024 entries, including 5729 peptide hormones, 40 peptide drugs and 255 marketed pharmaceutical preparations information. Each entry provided comprehensive information related to the peptide, including general information, sequence, activity, structure, physical information and literature information. We also added information on IC<sub>50</sub>, EC<sub>50</sub>, ED<sub>50</sub>, target, and whether or not the blood-brain barrier was crossed to the activity information note. In addition, HORDB integrates search and sequence analysis to facilitate user browsing and data analysis. We believe that the peptide hormones information collected by HORDB will promote the design and discovery of peptide hormones, All data are hosted and available in figshare 10.6084/m9.figshare.c.5522241.</p>
    </abstract>
    <abstract id="Abs2" abstract-type="summary">
      <p id="Par2">
        <table-wrap id="Taba">
          <table frame="hsides" rules="groups">
            <tbody>
              <tr>
                <td>Measurement(s)</td>
                <td>peptide hormone</td>
              </tr>
              <tr>
                <td>Technology Type(s)</td>
                <td>Comprehensive data website service</td>
              </tr>
              <tr>
                <td>Factor Type(s)</td>
                <td>peptide hormone</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Peptide hormones</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China (National Science Foundation of China)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>82073767</award-id>
        <award-id>82073767</award-id>
        <award-id>82073767</award-id>
        <award-id>82073767</award-id>
        <award-id>82073767</award-id>
        <principal-award-recipient>
          <name>
            <surname>Zhu</surname>
            <given-names>Ning</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>Fanyi</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Guobang</given-names>
          </name>
          <name>
            <surname>Lao</surname>
            <given-names>Xingzhen</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>Heng</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD2014-65)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background &amp; Summary</title>
    <p id="Par3">Since the appearance of insulin therapy in the 1920s, peptide have played an important role in the medical field<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. One advantage of peptide drugs is that they are highly specific, have low levels of toxicity and provide a variety of drug targets<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Nowadays, more than 60 peptide drugs have been approved for marketing, and over 150 peptides enter the clinical stage<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>.</p>
    <p id="Par4">Peptide hormones as therapeutic drugs have been widely used in the medical field. For example, exenatide is a synthetic glucagon like peptide-1 (GLP-1) analogue exendin-4, which consists of 30 amino acids<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Studies have shown that exenatide is superior to metformin in reducing weight, controlling blood sugar, improving liver enzymes and weakening NAFLD in T2DM patients with NAFLD<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Thymosin α 1 is a peptide composed of 28 amino acids, which has the functions of improving cellular immune function and regulating various immune functions. ZADAXIN, a drug developed by thymosin alpha 1, is approved in 35 countries for the treatment of viral infections, immunodeficiency, malignancies, and HIV/AIDS<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>.</p>
    <p id="Par5">In recent years, due to the great progress in the detection and quantification of peptides in biological matrices, the information about peptide hormones has increased dramatically. Large amounts of data is scattered, and it is difficult to access it centrally. There are many databases related to peptide (such as DRAMP<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, CancerPPD<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, APD<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, CAMP<sub>R3</sub><sup><xref ref-type="bibr" rid="CR13">13</xref></sup> etc.). These databases are used to store data on antimicrobial and anticancer peptides, but few databases on peptide hormones. As far as we know, Hmrbase<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> is a database specializing in hormones and receptors, but the data have not been updated since 2009. AHD 2.0<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> is the Arabidopsis thaliana plant hormone database, which does not contain peptide hormones data. In order to devote ourselves to the development of peptide hormones, we have built HORDB. As a comprehensive database of peptide hormones, HORDB not only collects the latest reported peptide hormones, but also comes from a wider range of sources. Such as from plants, animals, especially humans. Each entry consists of six categories: basic information, sequence, structure, activity, physics and documents. The database also includes information about peptide hormones in the market. We believe that with the development of artificial intelligence in peptide design, the data sets provided by HORDB will make it easier for researchers to develop prediction models of peptide hormones and accelerate the discovery of peptide hormones.</p>
    <p id="Par6">HORDB is an open user-friendly database. Includes two main data sets, peptide hormones and peptide hormones drug data set. Users can obtain peptide or drug information through simple, advanced search or browsing. The collection of sequence analysis tools facilitates the comparison of peptides with known sequences. HORDB covers a wide range, including plants, animals and humans, with rich information types, which is helpful for the development and utilization of peptide hormones. We have chosen the CC0 1.0 license and shared the data of HORDB with researchers. HORDB is available freely for public from <ext-link ext-link-type="uri" xlink:href="http://hordb.cpu-bioinfor.org">http://hordb.cpu-bioinfor.org</ext-link>.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Data collection and compilation</title>
      <p id="Par7">The peptide hormones of HORDB are collected from PubMed, Google Scholar, UniProt<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and PDB<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> by using keywords such as “hormone” and “peptide hormones”. These matches are registered in the database if the following conditions are met: (1) the known amino acid sequence of the peptide; (2) the length is less than 100 amino acids; (3) mature peptide sequence without the precursor and signal regions; (4) a function annotation as hormone or phytohormone from literature or database such as UniProt or PDB. The information of peptide hormones drugs extracted from the literature and DrugBank<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> in accordance with the above requirements. Except for the calculation of physical and chemical parameters using SciDBMaker<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, the rest of the information (like activity, 3-dimensional structure, sequence, etc.) is collected from literature and databases such as PDB<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, Uni-Prot<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, AlphaFold DB<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, etc.</p>
    </sec>
    <sec id="Sec4">
      <title>Database construction</title>
      <p id="Par8">The HORDB database is established on the standard platform of Linux-Apache-MySQL-PHP (LAMP) with Linux as the operating system, Apache(version 2.2.22) as the server, MySQL server (version 5.5.29) as data management. HTML, PHP and JavaScript are applied to develop the front-end web interface. The architecture of HORDB database is given in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Architecture of the datasets in HORDB.</p></caption><graphic xlink:href="41597_2022_1287_Fig1_HTML" id="d32e404"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec5">
    <title>Data Records</title>
    <sec id="Sec6">
      <title>Peptide information</title>
      <p id="Par9">information about peptide hormones is obtained manually from different sources. Each entry contains six parts: general information (ID, UniProt ID, protein name, gene name, source, family, disease, comments, external link), sequence information (sequence, length, pro-peptide, signal peptide, modification), activity (function, mechanism, target, IC<sub>50</sub>/EC<sub>50</sub>/ED<sub>50</sub>, cross BBB), Structure, physical information, literature (PubMed ID, title). In order to make the page more user-friendly, users can jump to related notes by clicking on the left navigation bar. Among them, the function information is the physiological function of the peptide hormones in the organism. The information in the structure information includes the 3-dimensional structure; The disulfide bond position point information indicates the existence of a disulfide bond at two amino acid positions by marking them. As shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Peptide information section screenshot. (<bold>a</bold>) General Information; (<bold>b</bold>) Sequence Information; (<bold>c</bold>) Physical Information; (<bold>d</bold>) Sequence Information; (<bold>e</bold>) Structure; (<bold>f</bold>) Literature.</p></caption><graphic xlink:href="41597_2022_1287_Fig2_HTML" id="d32e452"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Drug information</title>
      <p id="Par10">The drug information includes the following fields: ID, active ingredients, DrugBank Accession Number, Active Sequence, Sequence Length, Type, Description, Disease, CAS, Drug. The drug field embodies the drugs that the protein has been on the market: drug name, strength dosage form/route, company marketing status, Drug ID, approval year. Among them, the types of drugs are divided into small molecule drugs and biosynthetic drugs. The peptide hormones drug information collected in this database mainly comes from the DrugBank database and literature reports. The drug information is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. According to their functions, these drugs are manually sorted and analyzed manually. They can be divided into calcium regulators, blood sugar regulation, anti-inflammatory effects, antidiuretic effects, somatostatin-like activity, intestinal regulation, vasoconstriction, reproductive regulation and others, among others. The category includes reducing fat accumulation and dilating blood vessels. As shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Screenshot of drug information details.</p></caption><graphic xlink:href="41597_2022_1287_Fig3_HTML" id="d32e472"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Functional distribution of peptide hormones in HORDB.</p></caption><graphic xlink:href="41597_2022_1287_Fig4_HTML" id="d32e481"/></fig></p>
      <p id="Par11">According to statistics, the HORDB database has a total of 6024 entries, including 5729 peptide hormones, 40 peptide drugs and and 255 marketed pharmaceutical preparations information. There were 408 three-dimensional structure files of peptide hormones from the PDB<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> (54 structures) and the AlphaFold DB<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> (354 files), respectively. The statistical results of the main information entries are shown in the Fig. <xref rid="Fig5" ref-type="fig">5</xref>.<fig id="Fig5"><label>Fig. 5</label><caption><p>Number of entries corresponding to the main information.</p></caption><graphic xlink:href="41597_2022_1287_Fig5_HTML" id="d32e503"/></fig></p>
      <p id="Par12">All of our data sets were stored as tables, compressed packages, and text in figshare<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. “Peptide structure.zip” and “Peptide sequence.fasta.txt” for peptide structure (.pdb) and sequence information file (.fasta), respectively. Other excel files are used to store various kinds of information of peptide hormones, such as “Peptide hormones infomation.xlsx” used to store information of peptide hormones such as name, organization, source, activity, expression, structure, and so on; “Peptide Physical Information.xlsx” used to store information of physicochemical properties of peptide hormones. “Peptide Hormones Drugs Information.xlsx” and “Marketed Pharmaceuticals preparations infomation.xlsx” are used to store information on peptide drugs and their preparations. At the same time can also through our online database website browsing, use, download data, we will regularly update the data. The website is <ext-link ext-link-type="uri" xlink:href="http://hordb.cpu-bioinfor.org">http://hordb.cpu-bioinfor.org</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec8">
    <title>Technical Validation</title>
    <sec id="Sec9">
      <title>Data validation</title>
      <p id="Par13">We manually proofread and validate the main data of HORDB at the back end of the website. For peptide hormones data, we re-validated the number of primary information entries based on the MySQL metadata information. Check the accuracy of information by random sampling. For the metadata of MySQL database, in order to facilitate researchers and subsequent data sorting and updating, it was divided into four data tables, namely, peptide information master data (hor_gen), active pep (Active_PEP), peptide physical data (hor_phs) and market drug preparation data. All datasets are available on the download page.</p>
    </sec>
    <sec id="Sec10">
      <title>Data update</title>
      <p id="Par14">In addition to our regular updates, we also set up a submission page to encourage researchers to participate in HORDB data updates as contributors. Researchers can also give us any advice through the contact information on the homepage. With the deployment of the HORDB, we plan to update the data about every three months. In addition, when major changes that require version control occur, the production version of the database will be updated regularly.</p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Usage Notes</title>
    <p id="Par15">The homepage of HOROB contains the following interfaces: search, browse, tools, statistics, downloads and links. A brief description of the interface is given below, and a screenshot is given in Fig. <xref rid="Fig6" ref-type="fig">6</xref>.<fig id="Fig6"><label>Fig. 6</label><caption><p>Screenshots of HOROB web interfaces. (<bold>a</bold>) Basic navigation bar of HOROB homepage; (<bold>b</bold>) Shows the advanced search page.This interface allows users to query database by a combination of various conditions; (<bold>c</bold>) Display the result of query or browsing; (<bold>d</bold>) The download, browse list and BLAST<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> analysis interface is displayed; (<bold>e</bold>) Shows the detailed information page.</p></caption><graphic xlink:href="41597_2022_1287_Fig6_HTML" id="d32e564"/></fig></p>
    <sec id="Sec12">
      <title>Data retrieval or search tools</title>
      <p id="Par16">The database integrates simple search and advanced search to meet the different needs of users. Entering ID, name or sequence in the simple search box at the top of the page could retrieve the database. On the advanced search page, users combine keywords like ID, peptide name, family name, sequence, pro-peptide, length, source, target and other keywords to submit query content according to their requirements. The main web page of HORDB contains the following interfaces: Search, Browse, Tools, Statistics, Download and Links.</p>
    </sec>
    <sec id="Sec13">
      <title>Browse</title>
      <p id="Par17">To facilitate browsing, the database provides three cross-linked browse tables. (1) on the basis of biological sources, it is divided into plants, animals and humans; (2) on the basis of the data source, it is divided into peptide data and drug data. (3) on the basis of family classification, there are a total of 80 different family categories.</p>
    </sec>
    <sec id="Sec14">
      <title>Sequence alignment</title>
      <p id="Par18">The HORDB database furnishes the blast tool. Users submit their peptide sequences in FASTA format. The server performs a BLAST<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> search on the users’ query sequence for the amino acid sequence of all peptide in the database.</p>
    </sec>
    <sec id="Sec15">
      <title>Download</title>
      <p id="Par19">We are willing to share our data with users, so the website is designed with a download interface. The downloadable interface is divided into four parts: general information, physical information, peptide drug information, peptides sequence, peptide structure and listed drug information.</p>
    </sec>
    <sec id="Sec16">
      <title>HORDB data statistics</title>
      <p id="Par20">The current version of the HORDB database contains 6,024 entries, including 5,729 peptide hormones, 40 peptide drugs, and 255 pharmaceutical preparations on the market. 408 peptide hormones had available three-dimensional structures; They are collected from the PDB<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> and AlphaFoldDB<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Among them, 28 peptide hormones could cross the blood-brain barrier; 22 peptide hormones with clear disease information. In order to improve the understanding of the characteristics of peptide hormones and serve as the basis for the design of peptide hormones, the peptide sequences in the database were analyzed and counted. In the database, most peptide were derived from animals, as shown in Fig. <xref rid="Fig7" ref-type="fig">7</xref>. According to the protein classification criteria of UniProt<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, there are 80 families in the HORDB. The most abundant (856 in total) were the FMRFamide related peptide families, and the distribution of peptide hormones families is shown in Fig. <xref rid="Fig8" ref-type="fig">8</xref>. The peptide hormones shown in Fig. <xref rid="Fig9" ref-type="fig">9</xref> is mostly positively char. Among the peptide with known sequences, most peptide are about 10 amino acids in length (as shown in Fig. <xref rid="Fig10" ref-type="fig">10</xref>). The results showed that short peptide formed peptide hormones more easily than long peptide. As shown in Fig. <xref rid="Fig11" ref-type="fig">11</xref>, the proportion of hydrophobic residues in most peptide is 20–40%, indicating that most peptide hormones in HORDB are less hydrophobic. The distribution of amino acids is shown in Fig. <xref rid="Fig12" ref-type="fig">12</xref>. Arginine, glycine, leucine and serine are the main residues of natural peptide hormones. These findings may contribute to the development of peptide hormones models or the design of novel peptide hormones with higher activity.<fig id="Fig7"><label>Fig. 7</label><caption><p>Organsim distribution of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig7_HTML" id="d32e633"/></fig><fig id="Fig8"><label>Fig. 8</label><caption><p>Family Classification of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig8_HTML" id="d32e642"/></fig><fig id="Fig9"><label>Fig. 9</label><caption><p>Net charge distribution of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig9_HTML" id="d32e651"/></fig><fig id="Fig10"><label>Fig. 10</label><caption><p>Length distribution of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig10_HTML" id="d32e661"/></fig><fig id="Fig11"><label>Fig. 11</label><caption><p>Hydrophobic residue distribution of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig11_HTML" id="d32e670"/></fig><fig id="Fig12"><label>Fig. 12</label><caption><p>Amino acid distribution of peptide hormones.</p></caption><graphic xlink:href="41597_2022_1287_Fig12_HTML" id="d32e679"/></fig></p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>This work was supported by the National Natural Science Foundation of China (grant number 82073767), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD2014–65). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank for the calculation support of High-Performance Computing Center, China Pharmaceutical University,</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>Ning Zhu: Peptide hormones data collection, data validation and manuscript writing. Fanyi Dong: HORDB website construction, data collection. Guobang Shi: Test and revise the source code of HORDB database website. XingZhen Lao: Constructive suggestions for this work. Heng Zheng: Guide and supervise the whole process of this work.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>The source code for the HORDB database website has been uploaded to GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/CPU-HORDB/HORDB">https://github.com/CPU-HORDB/HORDB</ext-link>.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par21">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lau</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Dunn</surname>
            <given-names>MK</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic peptides:Historical perspectives,current development trends,and future directions</article-title>
        <source>Bioorganic &amp; Medicinal Chemistry</source>
        <year>2018</year>
        <volume>26</volume>
        <fpage>2700</fpage>
        <lpage>2707</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bmc.2017.06.052</pub-id>
        <pub-id pub-id-type="pmid">28720325</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fosgerau</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hoffmann</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Peptide therapeutics: current status and future directions</article-title>
        <source>Drug Discovery Today</source>
        <year>2015</year>
        <volume>20</volume>
        <fpage>122</fpage>
        <lpage>128</lpage>
        <pub-id pub-id-type="doi">10.1016/j.drudis.2014.10.003</pub-id>
        <?supplied-pmid 25450771?>
        <pub-id pub-id-type="pmid">25450771</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vlieghe</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lisowski</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Khrestchatisky</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Synthetic therapeutic peptides: science and market</article-title>
        <source>Drug Discovery Today</source>
        <year>2010</year>
        <volume>15</volume>
        <fpage>40</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="doi">10.1016/j.drudis.2009.10.009</pub-id>
        <?supplied-pmid 19879957?>
        <pub-id pub-id-type="pmid">19879957</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <mixed-citation publication-type="other">Müller, T. D. Glucagon-like peptide 1 (GLP-1). 59.</mixed-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hupe-Sodmann</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Endoproteolysis of Glucagon-like Peptide (GLP)-1(7–36) amide by Ectopeptidases in RINm5F Cells</article-title>
        <source>Peptides</source>
        <year>1997</year>
        <volume>18</volume>
        <fpage>625</fpage>
        <lpage>632</lpage>
        <pub-id pub-id-type="doi">10.1016/S0196-9781(97)00123-X</pub-id>
        <?supplied-pmid 9213354?>
        <pub-id pub-id-type="pmid">9213354</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garaci</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>From thymus to cystic fibrosis: the amazing life of thymosin alpha 1</article-title>
        <source>Expert Opinion on Biological Therapy</source>
        <year>2018</year>
        <volume>18</volume>
        <fpage>9</fpage>
        <lpage>11</lpage>
        <pub-id pub-id-type="doi">10.1080/14712598.2018.1484447</pub-id>
        <?supplied-pmid 30063868?>
        <pub-id pub-id-type="pmid">30063868</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garaci</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Historical review on thymosin α1 in oncology: preclinical and clinical experiences</article-title>
        <source>Expert Opinion on Biological Therapy</source>
        <year>2015</year>
        <volume>15</volume>
        <fpage>31</fpage>
        <lpage>39</lpage>
        <pub-id pub-id-type="doi">10.1517/14712598.2015.1017466</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease</article-title>
        <source>Arq Bras Endocrinol Metab</source>
        <year>2013</year>
        <volume>57</volume>
        <fpage>702</fpage>
        <lpage>708</lpage>
        <pub-id pub-id-type="doi">10.1590/S0004-27302013000900005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <mixed-citation publication-type="other">Sun, Q. &amp; Zhao, Z. Peptide Hormones as Tumor Markers in Clinical Practice. in <italic>The Enzymes</italic><bold>42</bold>, 65–79 (Elsevier, 2017).</mixed-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DRAMP 2.0, an updated data repository of antimicrobial peptides</article-title>
        <source>Sci Data</source>
        <year>2019</year>
        <volume>6</volume>
        <fpage>148</fpage>
        <pub-id pub-id-type="doi">10.1038/s41597-019-0154-y</pub-id>
        <?supplied-pmid 31409791?>
        <pub-id pub-id-type="pmid">31409791</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tyagi</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CancerPPD: a database of anticancer peptides and proteins</article-title>
        <source>Nucleic Acids Research</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>D837</fpage>
        <lpage>D843</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gku892</pub-id>
        <?supplied-pmid 25270878?>
        <pub-id pub-id-type="pmid">25270878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>APD: the Antimicrobial Peptide Database</article-title>
        <source>Nucleic Acids Research</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>590D</fpage>
        <lpage>592</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh025</pub-id>
        <pub-id pub-id-type="pmid">14752047</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Waghu</surname>
            <given-names>FH</given-names>
          </name>
          <name>
            <surname>Barai</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Gurung</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Idicula-Thomas</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>CAMP R3: a database on sequences, structures and signatures of antimicrobial peptides: Table 1</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <fpage>D1094</fpage>
        <lpage>D1097</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1051</pub-id>
        <?supplied-pmid 26467475?>
        <pub-id pub-id-type="pmid">26467475</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rashid</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Singla</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GP</given-names>
          </name>
        </person-group>
        <article-title>Hmrbase: a database of hormones and their receptors</article-title>
        <source>BMC Genomics</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>307</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-10-307</pub-id>
        <?supplied-pmid 19589147?>
        <pub-id pub-id-type="pmid">19589147</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>The UniProt Consortium.</collab>
        </person-group>
        <article-title>UniProt: a worldwide hub of protein knowledge</article-title>
        <source>Nucleic Acids Research</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D506</fpage>
        <lpage>D515</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1049</pub-id>
        <pub-id pub-id-type="pmid">30395287</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <mixed-citation publication-type="other">Burley, S. K. <italic>et al</italic>. Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive. in <italic>Protein Crystallography</italic> (eds. Wlodawer, A., Dauter, Z. &amp; Jaskolski, M.) <bold>1607</bold>, 627–641 (Springer New York, 2017).</mixed-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>DS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Research</source>
        <year>2018</year>
        <volume>46</volume>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
        <?supplied-pmid 29126136?>
        <pub-id pub-id-type="pmid">29126136</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hammami</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zouhir</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Naghmouchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ben Hamida</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fliss</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>SciDBMaker: new software for computer-aided design of specialized biological databases</article-title>
        <source>BMC Bioinformatics</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>121</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-9-121</pub-id>
        <?supplied-pmid 18298861?>
        <pub-id pub-id-type="pmid">18298861</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Varadi, M. <italic>et al</italic>. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. <italic>Nucleic Acids Research</italic> gkab1061 (20fi) 10.1093/nar/gkab1061.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="data">
        <name>
          <surname>Ning</surname>
          <given-names>Z</given-names>
        </name>
        <etal/>
        <year>2022</year>
        <data-title>HORDB, a comprehensive database of hormone peptide</data-title>
        <source>figshare</source>
        <pub-id pub-id-type="publisher-id" xlink:href="https://figshare.com/s/b156fd412820af9e6574">https://figshare.com/s/b156fd412820af9e6574</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>
        <source>Nucleic Acids Research</source>
        <year>1997</year>
        <volume>25</volume>
        <fpage>3389</fpage>
        <lpage>3402</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id>
        <?supplied-pmid 9254694?>
        <pub-id pub-id-type="pmid">9254694</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
